Natural killer cells in liver disease
- PMID: 23111952
- PMCID: PMC3573257
- DOI: 10.1002/hep.26115
Natural killer cells in liver disease
Abstract
Natural killer (NK) cells are enriched in lymphocytes within the liver and have unique phenotypic features and functional properties, including tumor necrosis factor-related apoptosis-inducing ligand-dependent cytotoxicity and specific cytokine profiles. As a key component of innate immunity in the liver, NK cells perform critical roles in host defense against pathogens and tumors through their natural cytotoxicity and cytokine production, and they also act as regulatory cells by engaging in reciprocal interactions with other types of liver cells through cell-to-cell contact and the production of cytokines. Accumulating evidence from the last decade suggests that NK cells play an important role in controlling viral hepatitis, liver fibrosis, and liver tumorigenesis, but also contribute to the pathogenesis of liver injury and inflammation. The characterization of intrahepatic NK cell functions has not only helped us to better understand the pathogenesis of liver disease, but has also revealed new therapeutic targets for managing this disease.
Copyright © 2012 American Association for the Study of Liver Diseases.
Figures
Similar articles
-
Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.J Immunol Res. 2018 Sep 4;2018:1206737. doi: 10.1155/2018/1206737. eCollection 2018. J Immunol Res. 2018. PMID: 30255103 Free PMC article. Review.
-
Natural killer cell receptors and their ligands in liver diseases.Med Mol Morphol. 2009 Mar;42(1):1-8. doi: 10.1007/s00795-008-0434-7. Epub 2009 Mar 18. Med Mol Morphol. 2009. PMID: 19294486 Review.
-
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.J Hepatol. 2010 Mar;52(3):322-9. doi: 10.1016/j.jhep.2009.12.005. Epub 2010 Jan 6. J Hepatol. 2010. PMID: 20133006
-
Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase.Hepatology. 2012 Aug;56(2):747-59. doi: 10.1002/hep.25694. Epub 2012 Jul 6. Hepatology. 2012. PMID: 22392635 Free PMC article.
-
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.Gastroenterology. 2006 Feb;130(2):435-52. doi: 10.1053/j.gastro.2005.10.055. Gastroenterology. 2006. PMID: 16472598
Cited by
-
Therapeutic restoration of miR-126-3p as a multi-targeted strategy to modulate the liver tumor microenvironment.Hepatol Commun. 2024 Feb 14;8(3):e0373. doi: 10.1097/HC9.0000000000000373. eCollection 2024 Mar 1. Hepatol Commun. 2024. PMID: 38358374 Free PMC article.
-
New and Old Key Players in Liver Cancer.Int J Mol Sci. 2023 Dec 5;24(24):17152. doi: 10.3390/ijms242417152. Int J Mol Sci. 2023. PMID: 38138981 Free PMC article. Review.
-
Tg1.4HBV-s-rec mice, a crossbred hepatitis B virus-transgenic model, develop mild hepatitis.Sci Rep. 2023 Dec 20;13(1):22829. doi: 10.1038/s41598-023-50090-8. Sci Rep. 2023. PMID: 38129531 Free PMC article.
-
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.Cell Metab. 2023 Nov 7;35(11):1852-1871. doi: 10.1016/j.cmet.2023.10.009. Cell Metab. 2023. PMID: 37939656 Review.
-
Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase Inhibition in Alcohol-Associated Liver Disease.Am J Pathol. 2024 Jan;194(1):71-84. doi: 10.1016/j.ajpath.2023.09.016. Epub 2023 Nov 3. Am J Pathol. 2024. PMID: 37925018
References
-
- Ishiyama K, Ohdan H, Ohira M, Mitsuta H, Arihiro K, Asahara T. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology. 2006;43:362–372. - PubMed
-
- Vermijlen D, Luo D, Froelich CJ, Medema JP, Kummer JA, Willems E, et al. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway. J Leukoc Biol. 2002;72:668–776. - PubMed
-
- Krämer BKC, Kebschull M, Glässner A, Eisenhardt M, Nischalke HD, Alexander M, Sauerbruch T, Spengler U, Nattermann J. NKp46(High) expression defines a NK cell subset that is potentially involved in control of HCV replication and modulation of liver fibrosis. Hepatology. 2012 in press. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials